OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials
Chang‐Jiang Deng, Yan Ju, Ying-Ying Zheng, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e070827-e070827
Open Access | Times Cited: 7
Chang‐Jiang Deng, Yan Ju, Ying-Ying Zheng, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e070827-e070827
Open Access | Times Cited: 7
Showing 7 citing articles:
Prognostic Value of Non-Traditional Lipid Indices for In-Hospital Mortality in Patients with Acute Coronary Syndromes
Rüstem Yılmaz, Kenan Toprak, Ahmet Karagöz, et al.
Medicina (2025) Vol. 61, Iss. 5, pp. 846-846
Open Access
Rüstem Yılmaz, Kenan Toprak, Ahmet Karagöz, et al.
Medicina (2025) Vol. 61, Iss. 5, pp. 846-846
Open Access
Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study
Ville Kytö, Aleksi Tornio
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100702-100702
Open Access | Times Cited: 2
Ville Kytö, Aleksi Tornio
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100702-100702
Open Access | Times Cited: 2
Are We Using Ezetimibe As Much As We Should?
Antonis A. Manolis, Theodora A. Manolis, Dimitri P. Mikhailidis, et al.
Biomarker Insights (2024) Vol. 19
Open Access | Times Cited: 1
Antonis A. Manolis, Theodora A. Manolis, Dimitri P. Mikhailidis, et al.
Biomarker Insights (2024) Vol. 19
Open Access | Times Cited: 1
Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis
Muhammad Hamayal, Warda Shahid, Chaudhary Humayun Akhtar, et al.
Future Cardiology (2024) Vol. 20, Iss. 11-12, pp. 639-650
Closed Access | Times Cited: 1
Muhammad Hamayal, Warda Shahid, Chaudhary Humayun Akhtar, et al.
Future Cardiology (2024) Vol. 20, Iss. 11-12, pp. 639-650
Closed Access | Times Cited: 1
Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database
Sara Bentzel, Charlotta Ljungman, Per Hjerpe, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 7, pp. 812-821
Closed Access | Times Cited: 2
Sara Bentzel, Charlotta Ljungman, Per Hjerpe, et al.
European Journal of Preventive Cardiology (2023) Vol. 31, Iss. 7, pp. 812-821
Closed Access | Times Cited: 2
Impact of eicosapentaenoic acid on cardiovascular outcomes after acute coronary syndrome: a systematic review and meta-analysis of randomized clinical trials
Parisa Fallahtafti, Sepehr Nayebirad, Elaheh Karimi, et al.
Cardiology Plus (2024) Vol. 9, Iss. 4, pp. 260-268
Open Access
Parisa Fallahtafti, Sepehr Nayebirad, Elaheh Karimi, et al.
Cardiology Plus (2024) Vol. 9, Iss. 4, pp. 260-268
Open Access
A Comparative Analysis of Low-Density Lipoprotein Cholesterol (LDL-C)-Lowering Activities of Bempedoic Acid, Inclisiran, and PCSK9 Inhibitors: A Systematic Review
Yazhini Rajendran, Madhumita Nandhakumar, Madhavi Eerike, et al.
Cureus (2024)
Open Access
Yazhini Rajendran, Madhumita Nandhakumar, Madhavi Eerike, et al.
Cureus (2024)
Open Access
